검색어 : 통합검색[Crowley Roger]
-
71
-
Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies
-
Munn‐
Chernoff, Melissa A.;
Johnson, Emma C.;
Chou, Yi‐
Ling;
Coleman, Jonathan R.I.;
Thornton, Laura M.;
Walters, Raymond K.;
Yilmaz, Zeynep;
Baker, Jessica H.;
Hü
bel, Christopher;
Gordon, Scott;
Medland, Sarah E.;
Watson, Hunna J.;
Gaspar, Hé
lé
na A.;
Bryois, Julien;
Hinney, Anke;
Leppä
, Virpi M.;
Mattheisen, Manuel;
Ripke, Stephan;
Yao, Shuyang;
Giusti‐
Rodrí
guez, Paola;
Hanscombe, Ken B.;
Adan, Roger A.H.;
Alfredsson, Lars;
Ando, Tetsuya;
Andreassen, Ole A.;
Berrettini, Wade H.;
Boehm, Ilka;
Boni, Claudette;
Boraska Perica, Vesna;
Buehren, Katharina;
Burghardt, Roland;
Cassina, Matteo;
Cichon, Sven;
Clementi, Maurizio;
Cone, Roger D.;
Courtet, Philippe;
Crow, Scott;
Crowley, James J.;
Danner, Unna N.;
Davis, Oliver S.P.;
de Zwaan, Martina;
Dedoussis, George;
Degortes, Daniela;
DeSocio, Janiece E.;
Dick, Danielle M.;
Dikeos, Dimitris;
Dina, Christian;
Dmitrzak‐
Weglarz, Monika;
Doca;
Department of Psychiatry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA;
Department of Psychiatry Washington University School of Medicine Saint Louis Missouri USA;
Department of Psychiatry Washington University School of Medicine Saint Louis Missouri USA;
Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK;
Department of Psychiatry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA;
Analytic and Translational Genetics Unit, Department of Medicine Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA;
Department of Psychiatry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA;
Department of Psychiatry University of North Carolina at Chapel Hill Chapel Hill North Carolina USA;
Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscie;
(Addiction biology,
v.26,
2021,
pp.e12880)
-
72
-
Risk of meningomyelocele mediated by the common 22q11.2 deletion
-
Vong, Keng Ioi;
Lee, Sangmoon;
Au, Kit Sing;
Crowley, T. Blaine;
Capra, Valeria;
Martino, Jeremiah;
Haller, Meade;
Araú
jo, Camila;
Machado, Hé
lio R.;
George, Renee;
Gerding, Bryn;
James, Kiely N.;
Stanley, Valentina;
Jiang, Nan;
Alu, Kameron;
Meave, Naomi;
Nidhiry, Anna S.;
Jiwani, Fiza;
Tang, Isaac;
Nisal, Ashna;
Jhamb, Ishani;
Patel, Arzoo;
Patel, Aakash;
McEvoy-Venneri, Jennifer;
Barrows, Chelsea;
Shen, Celina;
Ha, Yoo-Jin;
Howarth, Robyn;
Strain, Madison;
Ashley-Koch, Allison Elizabeth;
Azam, Matloob;
Mumtaz, Sara;
Bot, Gyang Markus;
Finnell, Richard H.;
Kibar, Zoha;
Marwan, Ahmed I.;
Melikishvili, Gia;
Meltzer, Hal S.;
Mutchinick, Osvaldo M.;
Stevenson, David A.;
Mroczkowski, Henry J.;
Ostrander, Betsy;
Schindewolf, Erica;
Moldenhauer, Julie;
Zackai, Elaine H.;
Emanuel, Beverly S.;
Garcia-Minaur, Sixto;
Nowakowska, Beata A.;
Stevenson, Roger E.;
Zaki, Maha S.;
Northrup, Hope;
McNamara, Hanna K.;
Aldinger, Kimberly A;
Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.;
Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.;
Department of Pediatrics, McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) and Children’s Memorial Hermann Hospital, Houston, TX 77030, USA.;
22q and You Center, Division of Human Genetics, Children’s Hospital of Philadelphia and Department of Pediatrics, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA 19104, USA.;
Genomics and Clinical Genetics Unit, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.;
Division of Nephrology, Department of Medicine, Columbia University, NY 10027, USA.;
Center for Reproductive Medicine, Department of Molecular and Cellular Biology and Scott Department of Urology, Baylor College of Medicine, TX 77030, USA.;
Department of Surgery and Anatomy, Ribeirã
o Preto Medical School, Univ;
(Science,
v.384,
2024,
pp.584-590)
-
73
-
A Phase II study of Viagenpumatucel-l (HS-110) in combination with low-dose Cyclophosphamide versus physician's choice in patients with advanced non-small cell lung cancer
-
Cohen, Roger B;
Nemunaitis, John;
Gabrail, Nashat;
Bazhenova, Lyudmila;
Schreiber, Taylor H;
Price, Melissa;
University of Pennsylvania School of Medicine, Philadelphia, PA, USA;
Mary Crowley Medical Research Center, Dallas, TX, USA;
Gabrail Cancer Center, Canton, OH, USA;
University of California San Diego, CA, USA;
Heat Biologics, Durham, NC, USA;
Heat Biologics, Durham, NC, USA;
(Journal for immunotherapy of cancer,
v.2,
2014,
pp.P82-P82)
-
74
-
Book reviews
-
Watson, Michael;
Lebduska, Lisa;
Collier, Ute;
Jordan, Andrew;
Thomson, Jo Traill;
Beaney, Peter;
Bailey, Christopher J.;
Laferriere, Eric;
Van Der Straaten, Jan;
Quin, Fraser S.;
Bluhdorn, Ingolfur;
Smith, Mick;
Dobson, Andrew;
Smith, Adrian;
Crowley, Kate;
Hay, P. R.;
Stephens, Piers H. G.;
University of Wales, Aberystwyth;
Roger Williams University,;
European University Institute, Florence;
CSERGE, Norwich and London;
University of Edinburgh,;
Staffordshire University,;
Keele University,;
McGill University,;
European Centre for Nature Conservation, Tilburg University,;
Edinburgh University,;
De Montfort University,;
University of Stirling,;
Keele University,;
University of Sussex,;
University of Tasmania,;
University of Tasmania,;
University of Manchester,;
(Environmental politics,
v.4,
1995,
pp.148-168)
-
75
-
First interim exploratory analysis of immune response in patients with advanced non-small cell lung cancer receiving viagenpumatucel-l (HS-110) in combination with low-dose cyclophosphamide in an ongoing phase II trial.
-
Cohen, Roger B.;
Morgensztern, Daniel;
Walsh, William Vincent;
Bazhenova, Lyudmila;
Melnyk, Anton M.;
Beck, J. Thaddeus;
Nemunaitis, John J.;
Schreiber, Taylor Houghton;
Price, Melissa Leigh;
University of Pennsylvania, Jenkintown, PA;
Washington University School of Medicine in St. Louis, St. Louis, MO;
University of Massachusetts Medical School, Worcester, MA;
UC San Diego Moores Cancer Center, La Jolla, CA;
US Oncology Research, LLC, McKesson Specialty Health, The Woodlands, TX, and Texas Oncology, Abilene, TX;
Highlands Oncology Group, Fayetteville, AR;
Mary Crowley Cancer Research Centers, Dallas, TX;
Heat Biologics Inc, Durham, NC;
Heat Biologics, Durham, NC;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.33,
2015,
pp.3077-3077)
-
76
-
A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2 positive tumors: Interim results.
-
Wainberg, Zev A.;
Barve, Minal A.;
Hamilton, Erika Paige;
Brenner, Andrew Jacob;
Valdes, Frances;
Mita, Monica M.;
Gonzá
lez, Valeria;
Anand, Banmeet S.;
Burnett, Christine;
Pelham, Joshua;
Waltzman, Roger J.;
Strack, Thomas;
Van Tine, Brian A.;
UCLA David Geffen School of Medicine, Los Angeles, CA;
;
Mary Crowley Cancer Research, Dallas, TX;
;
Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;
;
University of Texas Health San Antonio Cancer Center, San Antonio, TX;
;
University of Miami, Miami, FL;
;
Cedars-Siani Hospital, Los Angeles, CA;
;
Translational Research in Oncology, Montevideo, Uruguay;
;
Molecular Templates, Inc., Jersey City, NJ;
;
Molecular Templates, Inc., Jersey City, NJ;
;
Molecular Templates, Inc., Jersey City, NJ;
;
Molecular Templates, Inc., Jersey City, NJ;
;
Molecular Templates, Inc., Jersey City, NJ;
;
Division of Medical Oncology, Washington University School of Medicine, Saint Louis, MO;
(Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
v.38,
2020,
pp.e15567-e15567)